Sands Capital Ventures
ALMR icon

Sands Capital Ventures’s Alamar Biosciences ALMR Stock Holding History

Sands Capital Ventures’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$144M Hold
4,230,926
– – 20.75% 1
2026
Q2 		$115M Buy
+4,230,926
New +$95.7M 18.68% 1

Other funds holding ALMR

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Sands Capital Ventures's ALMR Position: Q3 2026 in Review

Sands Capital Ventures held its Alamar Biosciences (ALMR) position steady in Q3 2026 at 4,230,926 shares worth $144M. The position accounts for 20.75% of the portfolio, ranked #1.

Sands Capital Ventures first reported a position in ALMR in Q2 2026 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold ALMR as of Q3 2026.

  • Sands Capital Ventures held 4,230,926 shares of Alamar Biosciences worth $144M as of Q3 2026.
  • Sands Capital Ventures left its Alamar Biosciences share count unchanged in Q3 2026.
  • Alamar Biosciences made up 20.75% of Sands Capital Ventures's portfolio in Q3 2026, its #1 holding.
  • Sands Capital Ventures first reported a position in Alamar Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held Alamar Biosciences as of Q3 2026.

Based on Sands Capital Ventures's 13F filing for Q3 2026, filed 13 Nov 2026.